Allergan, Inc., the #1 Global Medical AestheticsCompany, and Clinique, the #1 Prestige Cosmetics...

-- New Line to Address Need for Specialized Skin Care as Medical Aesthetics Market Grows and to Be Sold Exclusively in Physicians' Offices --

IRVINE, Calif. & NEW YORK -- Allergan, Inc. (NYSE:AGN) and Clinique Laboratories, LLC, today announced a strategic collaboration which combines

Clinique's expertise in product development and formulation with Allergan's leadership in the medical aesthetics market. The new skin care line, which will incorporate the Clinique brand name, will offer clinically proven skin care products to complement in-office aesthetic procedures. It will be sold exclusively in physicians' offices in the United States and is expected to launch in the fall of 2008.

Over the past ten years, non-surgical aesthetic procedures have increased nearly 750 percent, with consumers in the United States spending more than $12 billion on cosmetic procedures in 20061. The top five non-surgical aesthetic treatments in 2006, administered in the physician's office, included BOTOX([R]) Cosmetic and hyaluronic acid dermal fillers such as JUVEDERM([TM]), laser hair removal, microdermabrasion and laser skin resurfacing. As more patients seek advice and treatments from aesthetic specialty physicians, there is a similar, growing trend of consumers purchasing skin care products in the physician's office. Allergan and Clinique expect to pioneer a new category of best-in-class skin care products sold exclusively in physicians' offices that will be Allergy Tested and 100% Fragrance Free.

"In collaboration with Clinique, our goal is to establish a leadership position in physician-dispensed skin care by offering a one-stop approach to specialized skin care products under a brand name that is trusted by consumers and backed by science on which physicians can rely," said David E.I. Pyott, Allergan's Chairman of the Board and Chief Executive Officer. "The collaboration combines Allergan's leadership in medical aesthetics and our deep understanding of the physician channel based on our Total Facial Rejuvenation portfolio - including BOTOX([R]) Cosmetic, JUVEDERM([TM]) and our skin care product line, with Clinique's history of formulating leading consumer skin care products guided by dermatologists. Together with our complementary strengths, we expect Clinique and Allergan to grow this market."

"Clinique's promise to our consumers has always been to create dermatologist guided, Allergy Tested, 100% Fragrance Free products that address skin care needs. Today we are entering a new phase of our relationship with the medical community," said Lynne Greene, Global President, Clinique Laboratories. "By joining forces with Allergan, the number one medical aesthetics company, we are now able to service consumers who are under the care of a physician with this completely new class of products."